NPOMEDIUM SIGNALFINANCIAL10-K

NPO shows mixed financial performance with revenue growth and expanded operations offset by meaningfully reduced profitability and a substantial decline in cash position.

The company appears to be investing heavily in growth initiatives including acquisitions (Overlook Industries) and expanded capabilities in semiconductor and life sciences markets, but these investments are pressuring near-term profitability. The significant cash reduction combined with higher interest expenses suggests increased debt financing to fund growth strategy, which investors should monitor for execution risk.

Comparing 2026-02-19 vs 2025-02-21View on EDGAR →
FINANCIAL ANALYSIS

Revenue grew solidly by 17% to $1.5B with operating income advancing 13.6%, indicating healthy top-line momentum. However, net income declined meaningfully due to substantially higher interest expenses, while cash reserves dropped by roughly half to $114.7M. The company increased capital expenditures by 44% and R&D spending by 22%, signaling continued investment in growth but creating pressure on cash flow and profitability metrics.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
-51.5%
$236.3M→$114.7M

Cash declined 51.5% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Net Income
P&L
-44.4%
$72.9M→$40.5M

Net income declined 44.4% — review whether driven by operations, interest costs, or non-recurring items.

Capital Expenditure
Cash Flow
+44.3%
$29.1M→$42.0M

Capital expenditure jumped 44.3% — major investment cycle underway; assess returns on deployment.

Interest Expense
P&L
+26.4%
$35.6M→$45.0M

Interest costs rose 26.4% — monitor debt levels and coverage ratio in rising rate environment.

R&D Expense
P&L
+22%
$10.9M→$13.3M

R&D investment increased 22% — signals commitment to future product development, though near-term margin impact.

Revenue
P&L
+17%
$1.3B→$1.5B

Revenue growing 17% — solid top-line momentum, watch margins for quality of growth.

Current Assets
Balance Sheet
-14.6%
$512.3M→$437.7M

Current assets declined 14.6% — monitor working capital adequacy and short-term liquidity.

Operating Income
P&L
+13.6%
$142.3M→$161.6M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Inventory
Balance Sheet
+10.8%
$138.8M→$153.8M

Inventory built 10.8% — monitor whether demand supports this build or if write-downs may follow.

LANGUAGE CHANGES
NEW — 2026-02-19
PRIOR — 2025-02-21
ADDED
As of February 5, 2026, there were 21,248,001 shares of common stock of the registrant outstanding, which includes 174,141 shares of common stock held by a subsidiary of the registrant and accordingly are not entitled to be voted.
The incorporation was organized in connection with Goodrich s spin-off of its Engineered Industrial Products segment effected, by a distribution of the Company's common stock to existing Goodrich shareholders.
These initiatives, which include those described in Acquisitions and Dispositions below, have broadened our capabilities to provide critical solutions in growing semiconductor, life sciences, and test and measurement industries, in addition to the other diverse markets we serve.
As of December 31, 2025, our continuing operations had 15 primary manufacturing and service facility locations (approximately 50,000 square feet or larger) located in 8 countries, including the United States.
Our sales from continuing operations by geography in 2025, 2024 and 2023: 2025 2024 2023 (in millions) United States $ 647.1 $ 601.7 $ 640.3 Asia Pacific 247.3 210.1 183.1 Europe 162.4 152.4 149.6 Rest of World 86.5 84.5 86.3 Total $ 1,143.3 $ 1,048.7 $ 1,059.3 The Company's filings with the Securities and Exchange Commission (the "SEC") can be found on our website at www.enpro.com.
+7 more — sign up free →
REMOVED
Relates to the reclassification of the cash outflow for the purchase of the noncontrolling interests in a subsidiary from investing activities to financing activities within the calendar year 2022 consolidated statement of cash flow, which the registrant determined to be immaterial after applying the guidance in SAB No.
Refer to Notes to Consolidated Financial Statements included herein.
As of February 5, 2025, there were 21,190,297 shares of common stock of the registrant outstanding, which includes 176,465 shares of common stock held by a subsidiary of the registrant and accordingly are not entitled to be voted.
The incorporation was organized in anticipation of Goodrich s intended spin-off of its Engineered Industrial Products segment, named Enpro Industries, Inc., by a distribution of the Company's common stock to existing Goodrich shareholders.
These initiatives, which include those described in Acquisitions and Dispositions below, have widened our capabilities to provide solutions to the semiconductor, life sciences, and other leading-edge industries.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →